BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:18 PM
 | 
Aug 23, 2012
 |  BC Extra  |  Company News

Arbitrator sides with Glenmark in crofelemer dispute

The International Centre for Dispute Resolution (ICDR) ruled in favor of Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK; BSE:532296) in its dispute with Napo Pharmaceuticals Inc. (San Francisco, Calif.) over rights to diarrhea compound crofelemer. According to Glenmark, the ICDR...

Read the full 178 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >